Retinal vein occlusion (RVO) is a serious eye condition caused by the blockage of veins that carry blood away from the retina, leading to vision impairment or even loss. As one of the leading causes of vision problems in older adults, RVO requires prompt and effective treatment to prevent further complications.

Our clinical trials for retinal vein occlusion are designed to explore innovative therapies that aim to improve vision outcomes and enhance the quality of life for those affected. By participating in our RVO clinical trials, patients have access to cutting-edge treatments and personalized care from our expert ophthalmology team. Learn about our trials below!